Tehran University of Medical Sciences

Science Communicator Platform

Share By
The Validation of the Persian Version of the Id-Migraine Questionnaire Publisher Pubmed



Nasirzadeh A ; Ghasemi A ; Afsharisafavi A ; Nahayati MA ; Jahanshahi R ; Yavari E ; Farzan M ; Farzan M ; Bayati A ; Haghdoost F
Authors

Source: Medical sciences Published:2025


Abstract

Background: Migraine is often not diagnosed or treated properly, despite being a common condition. The ID-migraine is a brief, self-administered test developed as a valuable tool for screening and diagnosing migraine in primary care settings. The objective of the present study was to produce a Persian translation of the original ID-migraine, perform cultural adaptation, and evaluate its validity. Methods: Consecutive patients who attended two neurology clinics for headache were enrolled in the study. Diagnoses were established by headache specialists and were compared with the Persian ID-migraine results. Results: Among the 657 participants included, 470 (71.5%) were clinically diagnosed with migraine, 120 (18.2%) with tension-type headache, and 40 (6.1%) with cluster headache. The validity attributes of the Persian ID-migraine were as follows: sensitivity, 0.96 (95% CI, 0.93-0.98); specificity, 0.46 (95% CI, 0.35-0.56); positive predictive value, 0.86 (95% CI, 0.82-0.89); negative predictive value, 0.76 (95% CI, 0.63-0.87), and a misclassification error of 14.9%. The questionnaire's Kappa coefficient was 0.78. Conclusions: The Persian version of the ID-migraine questionnaire exhibited sufficient sensitivity and positive predictive value, along with an acceptable misclassification error. However, it demonstrated a deficient level of specificity and a considerably reduced negative predictive value. This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine
Other Related Docs
15. The Association of Dietary Phytochemical Index and Migraine Headaches, Journal of Iranian Medical Council (2020)
17. Pattern of Interleukin-17A and Interleukin-1Β in Migraine Patients, Journal of Kerman University of Medical Sciences (2024)